IOVA

IOVA Operating Cash Flow Growth

12.93%TTM

Period ending:

IOVA TTM Cash from Operations YoY %%
IOVA TTM Cash from Operations YoY %734.28%-4725.16%
2009-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

IOVA operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 67 observations from Dec 31, 2009 to Jun 30, 2026.

Iovance Biotherapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
12.929%
19.0208%
14.3264%
11.1404%
21.9546%
12.9831%
2.444%
-2.2868%
-16.0179%
-20.5521%
-23.5906%
-32.1959%
-27.4197%
-33.1804%
-28.4354%
-13.5782%
-19.7504%
-18.3546%
-11.1181%
-20.6457%
-10.9508%
-3.6609%
-29.1052%
-43.6611%
-61.7586%
-73.4296%
-56.929%
-50.6838%
-45.3541%
-44.6724%
-28.6371%
-29.6979%
-38.7608%
-65.7218%
-140.9361%
-158.0626%
-224.0339%
-140.9272%
-77.727%
-79.1898%
-43.9935%
-98.2216%
-112.9095%
-99.6555%
-107.3788%
-74.517%
-135.7399%
-244.3352%
-216.2776%
-215.5129%
-182.9805%
205.9513%
185.3198%
176.3285%
171.3067%
-28.6294%
-173.2385%
-465.2086%
-896.9635%
-1,361.4719%
-1,435.9287%
-1,543.6214%
-4,196.8231%
-1,532.416%
-807.9344%
-124.0076%
74.7867%

Compare operating cash flow growth

All IOVA financial metrics · IOVA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.